Picture

Dr. Andrew Hendifar @DrHendifar

I am a physician and scientist working to develop new medications for gastrointestinal malignancies -- particularly pancreatic cancer and neuroendocrine tumors. cedars-sinai.edu/Bios---Physici… Los Angeles Joined May 2013
  • Tweets
    611
  • Followers
    863
  • Following
    496
  • Likes
    358
Dr. Andrew Hendifar retweeted
jgong15 Profile Picture

Jun Gong @jgong15

2 weeks ago

So cool, colleague pointed this out to me today. Unexpected! But deeply honored to be on the cover @OncLive with esteemed #GI onc colleagues @DrElkhoueiry @rachnatshroff @AnwaarSaeed3 @covey_md Dr. Michael Morse onclive.com/publications/o… @CSCancerCenter

Dr. Andrew Hendifar retweeted
DrZuriMurrell Profile Picture

Dr Zuri A. Murrell @DrZuriMurrell

a month ago

Did you know? When caught early, colorectal cancer has a 90% survival rate. Sharing this post from @coloncancercoalition they have great resources available ➡️ coloncancercoalition.org

Dr. Andrew Hendifar retweeted
CSCancerCenter Profile Picture

Cancer at Cedars-Sinai @CSCancerCenter

a month ago

#CedarsSinaiCancer is excited to host the upcoming 5th Annual #GI Tumor Conference on 3/23. Register today! This will be led by course directors @DrHendifar, @jgong15 & @DrArsenOsipov. #CedarsSinai #Gastroenterology #tumor @CMECedarsSinai @CedarsSinaiMed cmecshs.org/gitumor2024

Dr. Andrew Hendifar retweeted
jgong15 Profile Picture

Jun Gong @jgong15

a month ago

Highlighting seminal work from #KOL speakers at the 5th Annual @CSCancerCenter GI Tumor Conf: Dr. Oliver Maddocks: #aminoacid restriction as a novel #PDAC therapeutic strategy pubmed.ncbi.nlm.nih.gov/28425994/ Mar 23, 2024. Register at cedars.cloud-cme.com/course/courseo… @OncoAlert @CMECedarsSinai

Dr. Andrew Hendifar retweeted
jgong15 Profile Picture

Jun Gong @jgong15

2 months ago

Highlighting seminal work from #KOL speakers at the 5th Annual @CSCancerCenter GI Tumor Conf: @DrNickNissen: Circulating cells/oncosomes in portal/periph blood for monitoring resectable #PDAC pubmed.ncbi.nlm.nih.gov/38360856/ Mar 23, 2024. Register at cedars.cloud-cme.com/course/courseo… @OncoAlert

DrHendifar Profile Picture

Dr. Andrew Hendifar @DrHendifar

3 months ago

Novel Molecular Twin Tool May Improve Precision Medicine Care in Patients With Pancreatic Cance - goo.gl/alerts/DnGkZj #GoogleAlerts

Dr. Andrew Hendifar retweeted
Dan_Theodorescu Profile Picture

Dan Theodorescu @Dan_Theodorescu

3 months ago

I’m thrilled by the publication of our @NatureCancer paper using #AI analysis of #multiomic datasets to predict outcomes in #pancreaticcancer patients. This work is the unveiling of the #CedarsSinaiCancer #MolecularTwin. #PDAC @CedarsSinaiMed @_CSVCC cedars-sinai.org/newsroom/cedar…

Dr. Andrew Hendifar retweeted
CSCancerCenter Profile Picture

Cancer at Cedars-Sinai @CSCancerCenter

5 months ago

#CedarsSinaiCancer is excited to announce Dr. Matthew Juarez is our #HemOnc Fellowship Match for AY24-25. We are thrilled to welcome Dr. Juarez to Cedars-Sinai! @AkilMerchantMD @DrHendifar @CedarsSinaiMed #FellowMatch #MatchDay #Match2024

DrHendifar Profile Picture

Dr. Andrew Hendifar @DrHendifar

6 months ago

TFOX or modified FLOT beats FOLFOX in advanced H2N negative gastric cancer. Better PFS,OS, and QOL. Potentially practice changing. Great session. #esmo23

DrHendifar Profile Picture

Dr. Andrew Hendifar @DrHendifar

6 months ago

Preopanc-2 surprisingly shows no difference between gem-crt vs folfirinox in the neoadjuvant setting. Generate trial shows superiority of gem-nab over folfiriinox and S-IROX in advanced pdac 17.1 vs 14 months. Great data that adds additional nuance to pdac care #ESMO23

DrHendifar Profile Picture

Dr. Andrew Hendifar @DrHendifar

6 months ago

RMC-6236 is a novel ras-on inhibitor binding cyclophilin-a and forming a tri-complex by binding the “on” conformation. Pdac and NSCLC with Kras g12x were included. ORR was 38%. A complete response in NSCLC with a G12V mutation. ORR in PDAC was 20%. Unbelievable. #ESMO23

DrHendifar Profile Picture

Dr. Andrew Hendifar @DrHendifar

6 months ago

Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research news-journal.com/biotech-compan… via @newsjournal Thank you @PanCAN for supporting new treatments for our patients.

DrHendifar Profile Picture

Dr. Andrew Hendifar @DrHendifar

7 months ago

SOS to the world #sting

DrHendifar Profile Picture

Dr. Andrew Hendifar @DrHendifar

7 months ago

Very fortunate to work with a great group of Hematology and Medical Oncology fellows and the best co-director ⁦@AkilMerchantMD⁩ @CSCancerCenter⁩ ⁦@CSCancerCenter⁩ ⁦

Dr. Andrew Hendifar retweeted
LACNETS Profile Picture

LACNETS @LACNETS

7 months ago

On Sept 25, Novartis announced the phase 3 NETTER-2 trial with radioligand therapy Lutathera® demonstrated statistically significant and clinically meaningful progression-free survival in first line advanced GEP-NETs. Read the press release here: tinyurl.com/mw9vv593.

DrHendifar Profile Picture

Dr. Andrew Hendifar @DrHendifar

7 months ago

Dr. Christine Iacobucci-Donahue with a fascinating discussion of subclonal drivers in PDAC at AACR meeting. Wondering if that could play a role in treatment resistance to future KRAS inhibitors? Non-specific inhibitors could potentially be better.

DrHendifar Profile Picture

Dr. Andrew Hendifar @DrHendifar

7 months ago

Old friends and new connections collaborating to fight pancreatic cancer. But first, a night out in Boston. ⁦@PanCANBoston⁩ ⁦@marcusnoel⁩

Dr. Andrew Hendifar retweeted
CSCancerCenter Profile Picture

Cancer at Cedars-Sinai @CSCancerCenter

10 months ago

#CedarsSinaiCancer is one of the few centers in our area offering hepatic artery infusion (HAI) pump #chemotherapy to treat #colorectalcancer patients whose disease has spread to inoperable #tumors on their liver. @AGangiMD @CedarsSinaiMed cedars-sinai.org/newsroom/targe…

Dr. Andrew Hendifar retweeted
jgong15 Profile Picture

Jun Gong @jgong15

10 months ago

Pleasure catching up w/@medpagetoday #ASCO23 to discuss PhIII HIMALAYA oral abstr on how #imAEs w/STRIDE are manageable & associated w/improved OS in #HCC, @CedarsSinai was a participating site medpagetoday.com/meetingcoverag… @CSCancerCenter @CedarsSinaiMed @hccconnectinfo @MedpageOnco

Dr. Andrew Hendifar retweeted
OncoThor Profile Picture

Thor Halfdanarson @OncoThor

11 months ago

NET-02 is now out in final version. Nal-Iri/5FU vs. docetaxel as 2nd line chemo for progressive extrapulm NECs. Kudos for the investigators for getting this done in a rare tumor but I do not expect this to change much. Better therapy sorely needed. thelancet.com/journals/eclin…

Trends for United States

Logan Thompson
1.428 posts
Lakers in 7
18,8 B posts
Colin Jost
15,5 B posts
Mike Perry
1.148 posts
Sulphur
5.938 posts
#BKFC
1.788 posts
#WHCD
21,8 B posts
#LakeShow
3.843 posts
Leafs
32,4 B posts
#VegasBorn
2.441 posts
#AEWCollision
22,5 B posts
Marner
12,5 B posts
Oklahoma
51 B posts
George Kirby
2.275 posts
Game 5
75,9 B posts
Darvin Ham
13,4 B posts
Ardmore
5.184 posts
Feds
54,3 B posts
Okemah
1.890 posts
Eichel
1.274 posts

You might like

Professor of Surgery, Pathology and Laboratory Medicine PHASE ONE Foundation Distinguished Chair Director, Cedars-Sinai Cancer
Dan Theodorescu
@Dan_Theodorescu
978 Followers
Oncologist at Vanderbilt University Medical Center focusing on gastrointestinal cancers and early phase drug development. I like dogs. Views are my own.
Dr. jordan berlin
@jordanberlin5
2K Followers
Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope
Jun Gong
@jgong15
1K Followers
Ruesch Center Director
John Marshall
@marshalj23
2K Followers
GI Oncologist @MayoClinic. Committed to making a difference in the lives of patients faced with cancer.
Jason Starr
@drjasonstarr
2K Followers
Cedars-Sinai Cancer, ranked #9 in the nation in 2021 by U.S. News & World Report.
Cancer at Cedars-Sina..
@CSCancerCenter
2K Followers
Chief of Research and Immunotherapy • ImmunoOncology • Phase I Clinical Trials • Melanoma • Cutaneous Oncology
Omid Hamid MD
@OmidHamidMD
5K Followers
Associate Professor & Chief of Gastrointestinal Medical Oncology @PittTweet @UPMCnews @UPMCHillmanCC
Anwaar Saeed
@AnwaarSaeed3
2K Followers
Carioca da Gema ( from Rio de Janeiro) , Science nerd, Astronomy lover, Dog’s dad and also a Medical Oncologist, GI oncologist #Pancreas #Biliary #CRC #Gastric
Joao Fogacci
@FogacciJoao
653 Followers
GI medical oncologist and researcher @ Univ of Kansas
Anup Kasi MD MPH
@anup_kasi
1K Followers
GI and NET Oncologist, @OHSU Knight Cancer Institute, Chief & Med Dir CHO and Knight-Legacy Collaborative, Dad, cycling & ski enthusiast!
Hagen Kennecke
@HKennecke
1K Followers
Physician scientist @JohnsHopkins @hopkinskimmel, focused on translational immunotherapy research for #HCC, #cholangiocarcinoma
Mark Yarchoan
@MarkYarchoan
2K Followers
GI Med Onc at Vanderbilt @VUMC; wife and mom of 2 daughters
Kristen Ciombor
@KristenCiombor
2K Followers
GI oncologist, translational researcher. Passionate cancer drug developer. #Cholangiocarcinoma #HCC #PancreaticCancer Father. Sports fan! Thoughts my own.
KModyMD
@kmody29
1K Followers
Oncologist at Mayo Clinic Arizona. Interest in neuroendocrine, GI tumors and EBM. Opinions are my own and not the views of employer
Bassam Sonbol
@sonbol_bassam
789 Followers